| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 7, 398-404, Copyright © 1985 by American Heart Association
L Raij, S Azar and WF Keane
The relationship between hypertension, ferritin-antiferritin mesangial
immune injury (FIC), and progressive glomerular damage was studied in
hypertensive (8% NaCl chow) Dahl salt-sensitive rats (DS) and in
spontaneously hypertensive rats (SHR). The glomeruli of SHR are protected
from the increased perfusion pressure that accompanies systemic
hypertension by preglomerular vasoconstriction, while the glomeruli of
hypertensive DS are not. Blood pressure, serum creatinine levels, urinary
protein excretion, and glomerular injury (assessed by semiquantitative
morphometric analysis) were determined in 20-week-old SHR and DS with FIC.
In addition, half of a group of 20-week-old SHR with FIC were
uninephrectomized and progression of glomerular injury was assessed 12
weeks later. Control rats for each of the groups did not receive FIC. Our
studies showed that more extensive mesangial expansion and
glomerulosclerosis developed in hypertensive DS with FIC than in rats
without FIC. Glomerular injury in DS with FIC affected cortical and deep
glomeruli. Similarly, hypertensive SHR with FIC had minimal damage in
cortical glomeruli. In deep glomeruli of SHR, mesangial expansion was
similar to that of DS, but glomerulosclerosis was absent. In SHR, a 50%
reduction in renal mass, a maneuver known to decrease preglomerular
vasoconstriction, resulted in mesangial expansion similar to that in DS in
cortical glomeruli while deep glomeruli developed mesangial expansion as
well as glomerulosclerosis. Our results suggest that when hypertension and
mesangial immune injury coexist with renal vasodilatation (as occurs in DS
with 2 kidneys and in SHR after uninephrectomy), they act synergistically
to induce progressive glomerular damage. Similar mechanisms may be
operative in hypertensive humans with glomerulonephritis and may condition
the rate of progression to renal insufficiency.
ARTICLES
Role of hypertension in progressive glomerular immune injury
This article has been cited by other articles:
![]() |
K. Khavandi, A. S. Greenstein, K. Sonoyama, S. Withers, A. Price, R. A. Malik, and A. M. Heagerty Myogenic tone and small artery remodelling: insight into diabetic nephropathy Nephrol. Dial. Transplant., February 1, 2009; 24(2): 361 - 369. [Full Text] [PDF] |
||||
![]() |
T. Mori, A. Polichnowski, P. Glocka, M. Kaldunski, Y. Ohsaki, M. Liang, and A. W. Cowley Jr. High Perfusion Pressure Accelerates Renal Injury in Salt-Sensitive Hypertension J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1472 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gnudi, S. M. Thomas, and G. Viberti Mechanical Forces in Diabetic Kidney Disease: A Trigger for Impaired Glucose Metabolism J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2226 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagase, S. Shibata, S. Yoshida, T. Nagase, T. Gotoda, and T. Fujita Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone Blocker Hypertension, June 1, 2006; 47(6): 1084 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Raij Nitric Oxide in Hypertension: Relationship With Renal Injury and Left Ventricular Hypertrophy Hypertension, January 1, 1998; 31(1): 189 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayakawa and L. Raij Nitric Oxide Synthase Activity and Renal Injury in Genetic Hypertension Hypertension, January 1, 1998; 31(1): 266 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayakawa and L. Raij The Link Among Nitric Oxide Synthase Activity, Endothelial Function, and Aortic and Ventricular Hypertrophy in Hypertension Hypertension, January 1, 1997; 29(1): 235 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Barba, F. P. Cappuccio, L. Russo, F. Stinga, R. Iacone, and P. Strazzullo Renal Function and Blood Pressure Response to Dietary Salt Restriction in Normotensive Men Hypertension, May 1, 1996; 27(5): 1160 - 1164. [Abstract] [Full Text] |
||||
![]() |
N. K. Hollenberg and L. Raij Angiotensin-Converting Enzyme Inhibition and Renal Protection: An Assessment of Implications for Therapy Arch Intern Med, November 8, 1993; 153(21): 2426 - 2435. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |